12 analyst firms have reported ratings in the last year. The last upgrade for Outlook Therapeutics Inc happened on March 27, 2024 when BTIG raised their price target to $50. BTIG previously had a ...

Shares of HP Inc. (NYSE:HPQ) tumbled about 10% premarket on Thursday after second quarter results and outlook saw investors ...

CIBC shares closed down 0.3 per cent on Thursday despite reporting “impressive” Canadian bank results, according to Mr.

JP Morgan analyst Lisa C. Gill revised her 2025 outlook on GoodRx Holdings (NASDAQ:GDRX) following the company’s ...